arginine methyl ester has been researched along with bradykinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohlich, ED; Nakamura, Y; Ono, H; Zhou, X | 1 |
| Blood, AB; Blood, Q; Blum-Johnston, C; Brunelle, A; Francis, M; Longo, LD; Pearce, WJ; Romero, M; Taylor, MS; Thorpe, RB; Wee, C; Wilson, R; Wilson, SM | 1 |
2 other study(ies) available for arginine methyl ester and bradykinin
| Article | Year |
|---|---|
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Body Weight; Bradykinin; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Organ Size; Protective Agents; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2001 |
Developmental acceleration of bradykinin-dependent relaxation by prenatal chronic hypoxia impedes normal development after birth.
Topics: Animals; Arginine; Bradykinin; Endothelium, Vascular; Hypoxia; Nitric Oxide; Nitric Oxide Synthase Type III; Pulmonary Artery; Sheep; Vasodilation | 2016 |